BIOLASE Alpha and Beta Analysis
| BIOLDelisted Stock | USD 0.05 0.02 27.46% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as BIOLASE. It also helps investors analyze the systematic and unsystematic risks associated with investing in BIOLASE over a specified time horizon. Remember, high BIOLASE's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to BIOLASE's market risk premium analysis include:
Beta (1.18) | Alpha (0.91) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
BIOLASE |
BIOLASE Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. BIOLASE market risk premium is the additional return an investor will receive from holding BIOLASE long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BIOLASE. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate BIOLASE's performance over market.| α | -0.91 | β | -1.18 |
BIOLASE Fundamentals Vs Peers
Comparing BIOLASE's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BIOLASE's direct or indirect competition across all of the common fundamentals between BIOLASE and the related equities. This way, we can detect undervalued stocks with similar characteristics as BIOLASE or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of BIOLASE's fundamental indicators could also be used in its relative valuation, which is a method of valuing BIOLASE by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare BIOLASE to competition |
| Fundamentals | BIOLASE | Peer Average |
| Return On Equity | -5.05 | -0.31 |
| Return On Asset | -0.27 | -0.14 |
| Profit Margin | (0.44) % | (1.27) % |
| Operating Margin | (0.45) % | (5.51) % |
| Current Valuation | 13.65 M | 16.62 B |
| Shares Outstanding | 33.4 M | 571.82 M |
| Shares Owned By Insiders | 0.32 % | 10.09 % |
BIOLASE Opportunities
BIOLASE Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | StockNews.com Initiates Coverage on BIOLASE - Defense World | 04/17/2024 |
2 | Acquisition by Schuler Education Foundation of 3745000 shares of BIOLASE at 0.4 subject to Rule 16b-3 | 05/01/2024 |
3 | BIOLASE to Release Quarterly Earnings on Monday - Defense World | 05/10/2024 |
4 | Biolase Reports 2024 First Quarter Results Reiterates Full-Year 2024 Guidance For Revenue Growth and Profitability | 05/13/2024 |
5 | BIOLASE, Inc. Q1 2024 Earnings Call Transcript | 05/14/2024 |
6 | BIOLASE Research Coverage Started at StockNews.com - Defense World | 06/12/2024 |
7 | Global Medical Laser Systems Market Size To Worth USD 15.89 Billion By 2033 CAGR of 13.20 | 06/21/2024 |
About BIOLASE Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including BIOLASE or other delisted stocks. Alpha measures the amount that position in BIOLASE has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
BIOLASE Upcoming Company Events
As portrayed in its financial statements, the presentation of BIOLASE's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BIOLASE's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of BIOLASE's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of BIOLASE. Please utilize our Beneish M Score to check the likelihood of BIOLASE's management manipulating its earnings.
| 26th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with BIOLASE
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in BIOLASE Stock
If you are still planning to invest in BIOLASE check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BIOLASE's history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |